A Randomized Clinical Trial of Trans-Dermal Nicotine Replacement in Pregnant African-American Smokers
- First Online:
We compared acceptability, adherence and efficacy of trans-dermal nicotine patches and cognitive behavioral therapy (Group 1) to cognitive behavioral therapy alone (Group 2) in minority pregnant smokers. This is a randomized controlled trial. 52 women were recruited during pregnancy with a mean gestational age 18.5 ± 5.0 weeks and followed through delivery. Randomization was by site and initial cotinine levels. Interventionists and interviewers were blinded to group assignment. Two different nicotine replacement therapy dosing regiments were administered according to the baseline salivary cotinine level. A process evaluation model summarized patient adherence. The main outcome measure was self-report of cessation since last visit, confirmed by exhaled carbon monoxide. Analyses of categorical and continuous measures were conducted as well as linear trend tests of salivary cotinine levels. Women lost to follow-up were considered treatment failures. Participants were on average 27.5 ± 5.4 years old, 81 % were single, 69 % unemployed and 96 % were Medicaid eligible. A process evaluation indicated patients in both groups were adherent to scheduled program procedures through Visit 4, but not for Visits 5 and 6. Confirmed quit rates were: at visit 3, 23 (Group 1) and 0 % (Group 2) (p = 0.02); at visits 4 and 5, no difference; at visit 6, 19 (Group 1) and 0 % (Group 2) (p = 0.05). Group 1 delivered infants with a mean gestational age of 39.4 weeks versus 38.4 weeks in Group 2 (p = 0.02). 73 % (52/71) of the eligible smokers agreed to participate and 65 % (17/26) of Group 1 completed the protocol (i.e. attended 6 visits). A comparison of Group 1 and 2 quit rates confirmed a non-significant difference.
KeywordsPregnancy African-Americans Smoking Nicotine replacement therapy
- 3.U.S. Department of Health and Human Services. (2010). How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and health Promotion, Office on Smoking and Health. Retrieved from http://www.surgeongeneral.gov/library/tobaccosmoke/report/full_report.pdf.
- 4.National Center for Health Statistics. (2010). Health, United States, 2009: With Special Feature on Medical Technology. Hyattsville, MD. Retreived from http://www.cdc.gov/nchs/data/hus/hus09.pdf.
- 5.Fiore, M. C., Bailey, W. C., Cohen, S. J., Dorfman, S. F., Goldstein, M. G., & Gritz, E. R. (2000). Treating tobacco use and dependence: Clinical practice guideline. Rockville, MD: USDHHS, Public Health Service.Google Scholar
- 7.Windsor, R. (2010). Behavioral treatment methods for pregnant smokers: The evidence-base for prenatal care programs and professional practice. In A. Handler, J. Kennedy, & N. Peacock (Eds.), Reducing racial/ethnic disparities in reproductive and perinatal outcomes: The evidence from population-based interventions (pp. 239–264). New York: Springer.Google Scholar
- 9.Windsor, R., Oncken, C., Henningfield, J., Hartmann, K., & Edwards, N. (2005). Behavioral and pharmacological treatment methods for pregnant smokers: Issues for clinical practice. Journal of American Medical Women’s Association, 55, 304–310.Google Scholar
- 12.American College of Obstetricians and Gynecologists. (2011). Smoking Cessation during Pregnancy. A Clinician’s Guide to Helping Pregnant Women Quit Smoking. 2011 Self-instructional Guide and Tool Kit. An Educational Program from the American College of Obstetricians and Gynecologists. Retrieved from http://www.acog.org/departments/healthIssues/scdp/files/scdp.pdf.
- 17.Swamy, G. K., Roelands, J. J., Peterson, B. L., Fish, L. J., Oncken, C.A., Pletsch, P.K., et al. (2009). Predictors of adverse events among pregnant smokers exposed in a nicotine replacement therapy trial. American Journal of Obstetrics and Gynecology, 201(4), 354e1–354e7.Google Scholar
- 18.Physicians’ desk reference (2003) Oradell, NJ: Medical Economics Co.Google Scholar
- 19.Thornberry, J., Bhaskar, B., Krulewitch, C. J., Wesley, B., Hubbard, M. L., Das, A., et al. (2002). Audio computerized self-report interview use in prenatal clinics: Audio computer-assisted self interview with touch screen to detect alcohol consumption in pregnant women: Application of a new technology to an old problem. Computers, Informatics, Nursing, 20, 46–52.PubMedCrossRefGoogle Scholar
- 20.Windsor, R. A., Woodby, L. L., Miller, T. M., Hardin, J. M., Crawford, M. A., & DiClemente, C. C. (2000). Effectiveness of Agency for Health Care Policy and Research clinical practice guideline and patient education methods for pregnant smokers in Medicaid maternity care. American Journal of Obstetrics and Gynecology, 182(1 Pt 1), 68–75.PubMedCrossRefGoogle Scholar
- 21.Beck, A. T., Steer, R. A., & Brown, G. K. (2000). BDI-II fast screen for medical patients’ manual. London: The Psychological Corporation.Google Scholar
- 22.Windsor, R. (2000). A Pregnant woman’s guide to quit smoking. The Society for Public Health Education; SOPHE, 10 G St. Suite 605, Washington DC, 20002.Google Scholar
- 23.Windsor, R., Whiteside Jr., H. P., Solomon, L. J., Prows, S. L., Donatelle, R. J., Cinciripini, P. M., et al. (2000). A process evaluation model for patient education programs for pregnant smokers. Tobacco Control, 9(S. 3), III29–35.Google Scholar
- 27.Lassen, T. H., Madsen, M., Skovgaard, L. T., Strandberg-Larsen, K., Olsen, J., & Andersen, A.-M. N. (2010). Naterbak use of nicotine replacement therapy during pregnancy and offspring birthweight: a study within the Danish National Birth Cohort. Paediatric and Perinatal Epidemiology, 24, 272–281.PubMedCrossRefGoogle Scholar